MedTrace Logo

Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer

NCT02176902 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 107

Last updated 2025-02-10

No results posted yet for this study

Summary

This randomized phase II trial will evaluate if a low omega-6, high omega-3 fat diet combined with fish oil has the potential to delay disease progression in patients with prostate cancer undergoing active surveillance.

Conditions

  • Adenocarcinoma of the Prostate
  • Stage I Prostate Cancer
  • Stage IIA Prostate Cancer
  • Stage IIB Prostate Cancer

Interventions

BEHAVIORAL

behavioral dietary intervention

Receive dietary counseling

BEHAVIORAL

behavioral dietary intervention

Receive guidelines for low-fat diet

DIETARY_SUPPLEMENT

omega-3 fatty acid

Given PO

OTHER

laboratory biomarker analysis

Correlative studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Pharmavite LLC

    collaborator INDUSTRY

  • Seafood Industry Research Fund

    collaborator UNKNOWN

  • Jonsson Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • William Aronson · Jonsson Comprehensive Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-01
Primary Completion
2023-04-19
Completion
2026-11-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02176902 on ClinicalTrials.gov